AI-Enhanced Cardiac Mapping and Ablation System

An advanced cardiac mapping and ablation system integrating AI-powered signal processing, cloud-based data analytics, and novel catheter designs for optimized personalized treatment planning and minimally invasive procedures.

The original patent's flexible circuit for use with a catheter and related manufacturing method has limitations in terms of real-time data analysis, personalized treatment planning, and minimally invasive procedures. The new inventive concept addresses these limitations by incorporating AI-powered signal processing, cloud-based data analytics, and advanced catheter designs to provide real-time cardiac mapping, optimized ablation therapy, and personalized treatment planning.

The AI-enhanced cardiac mapping and ablation system comprises a flexible circuit for a catheter tip with integrated AI-powered signal processing, a cloud-based data analytics platform, and novel catheter designs incorporating shape-memory alloy components, micro-electro-mechanical systems (MEMS), and integrated ultrasound transducers. The system enables real-time cardiac mapping, optimized ablation therapy, and personalized treatment planning through machine learning algorithms and cloud-based data analytics. The novel catheter designs provide enhanced maneuverability and real-time visualization during minimally invasive procedures.

The new inventive concept's integration of AI-powered signal processing, cloud-based data analytics, and advanced catheter designs provides a significant departure from the original patent's flexible circuit design. The use of machine learning algorithms, generative adversarial networks, and real-time feedback loops to optimize ablation therapy and personalize treatment planning represents a substantial inventive step.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, alternative catheter designs, or the integration of additional sensors or imaging modalities. Variations of the system could be tailored to specific cardiac arrhythmias or patient populations, further expanding the scope of the inventive concept.

The AI-enhanced cardiac mapping and ablation system has significant commercial potential in the electrophysiology and cardiac ablation markets, with potential applications in hospitals, clinics, and research institutions. The system's ability to provide personalized treatment planning and optimized ablation therapy could lead to improved patient outcomes, reduced healthcare costs, and increased market share for companies adopting this technology.